BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16463156)

  • 1. Value of proteomics applied to the follow-up in stem cell transplantation.
    Weissinger EM; Mischak H; Ganser A; Hertenstein B
    Ann Hematol; 2006 Apr; 85(4):205-11. PubMed ID: 16463156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary electrophoresis-mass spectrometry as a powerful tool in clinical diagnosis and biomarker discovery.
    Kolch W; Neusüss C; Pelzing M; Mischak H
    Mass Spectrom Rev; 2005; 24(6):959-77. PubMed ID: 15747373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics in uremia and renal disease.
    Mischak H; Massy ZA; Jankowski J
    Semin Dial; 2009; 22(4):409-16. PubMed ID: 19708992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes.
    Fliser D; Wittke S; Mischak H
    Electrophoresis; 2005 Jul; 26(14):2708-16. PubMed ID: 15966014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accurate diagnosis of acute graft-versus-host disease using serum proteomic pattern analysis.
    Srinivasan R; Daniels J; Fusaro V; Lundqvist A; Killian JK; Geho D; Quezado M; Kleiner D; Rucker S; Espina V; Whiteley G; Liotta L; Petricoin E; Pittaluga S; Hitt B; Barrett AJ; Rosenblatt K; Childs RW
    Exp Hematol; 2006 Jun; 34(6):796-801. PubMed ID: 16728285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics studies after hematopoietic stem cell transplantation.
    Weissinger EM; Zürbig P; Ganser A
    Methods Mol Biol; 2009; 506():437-52. PubMed ID: 19110643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Capillary electrophoresis-mass spectrometry for the analysis of intact proteins.
    Haselberg R; de Jong GJ; Somsen GW
    J Chromatogr A; 2007 Aug; 1159(1-2):81-109. PubMed ID: 17560583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CE-MS in biomarker discovery, validation, and clinical application.
    Mischak H; Schanstra JP
    Proteomics Clin Appl; 2011 Feb; 5(1-2):9-23. PubMed ID: 21280234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic data analysis workflow for discovery of candidate biomarker peaks predictive of clinical outcome for patients with acute myeloid leukemia.
    Forshed J; Pernemalm M; Tan CS; Lindberg M; Kanter L; Pawitan Y; Lewensohn R; Stenke L; Lehtiö J
    J Proteome Res; 2008 Jun; 7(6):2332-41. PubMed ID: 18452325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High resolution proteome/peptidome analysis of body fluids by capillary electrophoresis coupled with MS.
    Schiffer E; Mischak H; Novak J
    Proteomics; 2006 Oct; 6(20):5615-27. PubMed ID: 16991199
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of protein biomarkers in Dupuytren's contracture using surface enhanced laser desorption ionization time-of-flight mass spectrometry (SELDI-TOF-MS).
    O'Gorman D; Howard JC; Varallo VM; Cadieux P; Bowley E; McLean K; Pak BJ; Gan BS
    Clin Invest Med; 2006 Jun; 29(3):136-45. PubMed ID: 17058431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in capillary electrophoresis coupled to matrix-assisted laser desorption/ionization - time of flight mass spectrometry.
    Huck CW; Bakry R; Huber LA; Bonn GK
    Electrophoresis; 2006 Jun; 27(11):2063-74. PubMed ID: 16645982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface modified capillary electrophoresis combined with in solution isoelectric focusing and MALDI-TOF/TOF MS: a gel-free multidimensional electrophoresis approach for proteomic profiling--exemplified on human follicular fluid.
    Hanrieder J; Zuberovic A; Bergquist J
    J Chromatogr A; 2009 Apr; 1216(17):3621-8. PubMed ID: 19155017
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of hypopharyngeal squamous cell carcinoma using serum proteomics.
    Zhou L; Cheng L; Tao L; Jia X; Lu Y; Liao P
    Acta Otolaryngol; 2006 Aug; 126(8):853-60. PubMed ID: 16846929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X; Wang F; Li YG; Zhu GP; Zhang WM
    J Exp Clin Cancer Res; 2007 Dec; 26(4):505-8. PubMed ID: 18365545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
    Zhang GQ; Du J; Pang D
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Proteomics and breast cancer].
    Mathelin C; Tomasetto C; Cromer A; Rio MC
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1161-9. PubMed ID: 17123853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.